Novel potentials of the DPP-4 inhibitor sitagliptin against ischemia-reperfusion (I/R) injury in rat ex-vivo heart model
المؤلف | Al-Awar A. |
المؤلف | Alm?si N. |
المؤلف | Szab? R. |
المؤلف | Takacs I. |
المؤلف | Murlasits Z. |
المؤلف | Sz?cs G. |
المؤلف | T?r?k S. |
المؤلف | P?sa A. |
المؤلف | Varga C. |
المؤلف | Kupai K. |
تاريخ الإتاحة | 2020-02-24T08:57:14Z |
تاريخ النشر | 2018 |
اسم المنشور | International Journal of Molecular Sciences |
المصدر | Scopus |
الرقم المعياري الدولي للكتاب | 16616596 |
الملخص | Dipeptidyl peptidase-4 (DPP-4) inhibitors are a class of oral anti-diabetic drugs, implicated in pleiotropic secondary cardioprotective effects. The aim of the study was to unveil the unknown and possible cardioprotective targets that can be exerted by sitagliptin (Sitg) against ischemia-reperfusion (I/R) injury. Male wistar rats received 2 weeks? Sitg oral treatment of different doses (25, 50, 100, and 150 mg/kg/day), or saline as a Control. Hearts were then isolated and subjected to two different I/R injury protocols: 10 min perfusion, 45 min regional ischemia, and 120 min reperfusion for infarct size (IS) measurement, or: 10 min perfusion, 45 min regional ischemia and 10 min reperfusion for biochemical analysis: nitric oxide synthases (NOSs) and DPP-4 activity, glucagon-like peptide-1 (GLP-1), Calcium, transient receptor potential vanilloid (TRPV)-1 and calcitonin gene-related peptide (CGRP) levels, transient receptor potential canonical (TRPC)-1 and e-NOS protein expression. NOS inhibitor (L-NAME) and TRPV-1 inhibitor (Capsazepine) were utilized to confirm the implication of both signaling mechanisms in DPP-4 inhibition-induced at the level of IS. Findings show that Sitg (50 mg) resulted in significant decrease in IS and DPP-4 activity, and significant increase in GLP-1, NOS activity, e-NOS expression, TRPV-1 level and TRPC-1 expression, compared to controls. Results of CGRP are in line with TRPV-1, as a downstream regulatory effect. NOS system and transient receptor potential (TRP) channels can contribute to DPP-4 inhibition-mediated cardioprotection against I/R injury using Sitagliptin. |
راعي المشروع | This research was funded by GINOP grant number 2.3.2-15-2016-00035. |
اللغة | en |
الناشر | MDPI AG |
الموضوع | Calcitonin gene related peptide Dipeptidyl-peptidase-4 DPP-4 inhibitors Endothelial nitric oxide synthase Infarct size Ischemia-reperfusion injury NOS activity Transient receptor potential channels |
النوع | Article |
رقم العدد | 10 |
رقم المجلد | 19 |
الملفات في هذه التسجيلة
الملفات | الحجم | الصيغة | العرض |
---|---|---|---|
لا توجد ملفات لها صلة بهذه التسجيلة. |
هذه التسجيلة تظهر في المجموعات التالية
-
الأبحاث [96 items ]